Management of herpes simplex virus type 1 pneumonia following liver transplantation. 1996

P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
Abt. Anästhesiologie IV, Medizinische Hochschule Hannover, Germany.

Interstitial pneumonia caused by Herpes simplex virus type 1 (HSV-1) is a severe complication of orthotopic liver transplantation (LTX). The records of patients were reviewed who had an LTX at the age of 16 years or older between 1991 and 1994 with a mean follow-up of 21 months (range, 10 to 44 months). Six patients were included who had fever of > 38 degrees C, deterioration of arterial blood gases, radiological evidence of interstitial pneumonia and proof of HSV-1 in bronchoalveolar lavage fluid. All patients were anti-HSV-IgG positive before LTX. All patients were successfully treated with intravenous acyclovir, mechanical ventilation and reduced immunosuppression. Three patients who received cyclosporin A had a rejection which was successfully treated by switching to FK 506. Four patients were discharged in good health. One patient died 36 months after LTX of an unrelated cause. One patient died of urosepsis on postoperative day 139. Acyclovir together with mechanical ventilation and reduced immunosuppression proved to be an effective treatment for HSV-1 pneumonia following LTX.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012059 Rejection, Psychology Non-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection. Psychological Rejection,Rejection (Psychology),Psychology Rejection,Rejection, Psychological
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D005260 Female Females
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
January 1992, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
December 2021, Journal of intensive care medicine,
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
July 1999, Human gene therapy,
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
November 2010, General thoracic and cardiovascular surgery,
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
October 2012, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
October 2020, Virologie (Montrouge, France),
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
June 2003, Quintessence international (Berlin, Germany : 1985),
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
August 2004, Medizinische Klinik (Munich, Germany : 1983),
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
September 1996, The Pediatric infectious disease journal,
P Liebau, and E Kuse, and M Winkler, and H J Schlitt, and K Oldhafer, and W Verhagen, and J Flik, and R Pichlmayr
January 1998, The Journal of the Greater Houston Dental Society,
Copied contents to your clipboard!